CHONGQING SHUNBO ALUMINUM CO.(002996)
Search documents
顺博合金(002996.SZ):预计2025年净利润同比增长222.96%~315.23%
Ge Long Hui A P P· 2026-01-29 15:52
Core Viewpoint - Shunbo Alloy (002996.SZ) forecasts a significant increase in net profit for the fiscal year 2025, driven by strong demand in downstream industries and rising prices in the non-ferrous metal market [1] Financial Performance - The net profit attributable to shareholders is expected to be between 210 million to 270 million yuan, representing a year-on-year growth of 222.96% to 315.23% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 126 million to 186 million yuan, with a year-on-year increase of 33.19% to 96.62% [1] - Basic earnings per share are estimated to be between 0.32 yuan to 0.41 yuan [1] Market Dynamics - The overall demand in downstream industries and the price increase in the non-ferrous metal market have positively impacted the company's sales volume and prices of its main products [1] - The company has implemented efficiency reforms and cost reduction measures, which have contributed to the growth in revenue and operating profit year-on-year [1]
大华、众华收警示函!
梧桐树下V· 2026-01-29 15:20
Core Viewpoint - The article discusses the regulatory actions taken by the Chongqing Securities Regulatory Bureau against two accounting firms, Dahua and Zhonghua, for deficiencies in their audit practices, highlighting the importance of compliance with auditing standards and the need for improved quality control in financial reporting [1][9]. Group 1: Dahua Accounting Firm - Dahua Accounting Firm faced issues during the audit of Chongqing Huasen Pharmaceutical Co., Ltd.'s 2023 financial statements, including incomplete documentation in risk assessment and inadequate execution of substantive procedures [4][6]. - Specific deficiencies included incomplete risk assessment forms, insufficient evidence for control tests in the procurement and payment cycle, and inadequate substantive testing for inventory impairment and valuation [5][6]. - The firm was found to have violated multiple auditing standards and regulations, leading to the issuance of a warning letter and a requirement to enhance compliance and quality control measures [7]. Group 2: Zhonghua Accounting Firm - Zhonghua Accounting Firm encountered problems while auditing Chongqing Shunbo Aluminum Alloy Co., Ltd.'s 2024 financial report, particularly in risk assessment and substantive procedures [9][10]. - The audit documentation lacked records for reassessing materiality based on significant post-balance sheet events, and there were failures in executing revenue cutoff tests and impairment testing for receivables and inventory [11][12]. - Similar to Dahua, Zhonghua was also issued a warning letter for non-compliance with auditing standards, emphasizing the need for stricter adherence to regulations and improved audit quality [12].
产品量价齐升 顺博合金预计2025年净利润同比增长222.96%至315.23%
Zheng Quan Ri Bao Wang· 2026-01-29 13:41
Core Viewpoint - Chongqing Shunbo Aluminum Alloy Co., Ltd. (Shunbo Alloy) expects a significant increase in net profit for 2025, projecting a growth of 222.96% to 315.23% year-on-year, driven by strong demand in downstream industries and rising prices in the non-ferrous metal market [1] Group 1: Financial Performance - The company anticipates a net profit attributable to shareholders of 210 million to 270 million yuan for 2025, with a year-on-year growth of 222.96% to 315.23% [1] - The projected net profit after deducting non-recurring gains and losses is expected to be between 126 million and 186 million yuan, reflecting a year-on-year increase of 33.19% to 96.62% [1] Group 2: Market Dynamics - The overall demand in downstream industries and the strengthening of non-ferrous metal market prices have positively impacted the sales volume and prices of the company's main products [1] - The company has implemented efficiency reforms that have resulted in cost reductions, contributing to increased revenue and operating profit [1] Group 3: Production Capacity and Product Segments - In the casting aluminum alloy segment, Shunbo Alloy's Anhui subsidiary has a production capacity of 400,000 tons, while its Hubei subsidiary has a capacity of 200,000 tons, both of which have seen steady increases in production and sales [1] - In the aluminum plate segment, Chongqing Aobo Aluminum Material Manufacturing Co., Ltd. has a production capacity of 50,000 tons, with significant increases in sales of battery casing materials, primarily used in the new energy vehicle and energy storage industries [1] Group 4: Business Model and Strategy - Shunbo Alloy specializes in the production and sales of recycled aluminum alloy ingots, focusing on circular economy principles [2] - The company employs two pricing models: market-based pricing, which mitigates risks associated with raw material price fluctuations, and cost-plus pricing, which locks in raw material costs to ensure reasonable profits [2] - The company aims to develop its recycled aluminum business steadily, focusing on a dual strategy of "recycled casting aluminum alloy + recycled deformed aluminum alloy" while also advancing hazardous waste disposal [2]
30日投资提示:顺博合金财报信披不准确,收到监管函
集思录· 2026-01-29 13:34
Group 1 - Jintian Co., Ltd. plans to increase its shareholding by an amount between 50 million to 100 million yuan [1] - Jinpu Garden expects a full-year loss of 260 million to 210 million yuan for 2025 [1] - Hebang Biotechnology's shareholder intends to reduce its holdings by no more than 2% of the repurchased shares [1] Group 2 - Shunbo Alloy has received an administrative regulatory decision from the Chongqing Securities Regulatory Bureau due to inaccurate financial disclosures [1] - Mars Man expects a loss of 370 million to 270 million yuan for 2025 [1] - Seli Medical anticipates a net loss of 160 million to 209 million yuan for the 2025 fiscal year [1] Group 3 - Hongchuan Wisdom expects a full-year loss of 475 million to 443 million yuan for 2025 [1] - Various convertible bonds are listed, including Haomei Convertible Bond which will not be forcibly redeemed [2] - New stocks from Meidel and other companies are set to be listed on the Beijing Stock Exchange and Shanghai Stock Exchange [1]
顺博合金:预计2025年净利润同比增长222.96%至315.23%
Zheng Quan Ri Bao· 2026-01-29 12:47
证券日报网讯 1月29日,顺博合金发布公告称,公司预计2025年度归属于上市公司股东的净利润为 21000万元至27000万元,比上年同期增长222.96%至315.23%。 (文章来源:证券日报) ...
1月29日晚间重要公告一览
Xi Niu Cai Jing· 2026-01-29 10:13
Earnings Forecasts - Shengyi Electronics expects a net profit of 1.431 billion to 1.513 billion yuan in 2025, an increase of 331.03% to 355.88% year-on-year [1] - Tigermed anticipates a net profit of 830 million to 1.23 billion yuan in 2025, representing a growth of 105% to 204% year-on-year [2] - Shunbo Alloy forecasts a net profit of 210 million to 270 million yuan in 2025, with an increase of 222.96% to 315.23% year-on-year [3] - Jinkong Electric expects a net profit of 155 million to 195 million yuan in 2025, reflecting a growth of 383.21% to 507.9% year-on-year [9] - Baiao Saitu anticipates a net profit of 162 million to 182 million yuan in 2025, with a year-on-year increase of 384.26% to 443.88% [18] - Panjiang Co. expects a net profit of 318 million to 380 million yuan in 2025, representing a growth of 205.30% to 264.83% year-on-year [38] Loss Forecasts - Liaoning Energy predicts a net loss of 273 million to 410 million yuan in 2025, compared to a profit of 202 million yuan in the previous year [5] - Anbotong anticipates a net loss of 114 million to 165 million yuan in 2025, with a revenue decrease of 19.65% to 27.25% [7] - Wantai Bio forecasts a net loss of 330 million to 410 million yuan in 2025, compared to a profit of 106 million yuan in the previous year [12] - Xingyun Co. expects a net loss of 155 million to 230 million yuan in 2025, compared to a loss of 82.44 million yuan in the previous year [20] - Huaxing Co. anticipates a net loss of 800 million to 1.2 billion yuan in 2025, with a reduction in loss compared to 1.67 billion yuan in the previous year [46] New Product Approvals - Hengrui Medicine received acceptance for a new indication application for its innovative drug, combining Carrelizumab and Apatinib for treating unresectable liver cancer [4] - Tianen Kang's subsidiary received a drug registration acceptance notice for Lidocaine and Prilocaine aerosol [31] - Lisheng Pharmaceutical announced that its Aminophylline tablets passed the consistency evaluation for generic drugs [40] Share Buyback Plans - Hengyuan Coal Power plans to repurchase shares with a total amount not less than 200 million yuan and not exceeding 250 million yuan [13] Contract Wins - China Communication Signal Co. won contracts totaling approximately 5.26 billion yuan for 21 important projects in the railway and urban rail transit markets [37]
顺博合金(002996) - 关于担保事项的进展公告
2026-01-29 09:00
| 证券代码:002996 | 证券简称:顺博合金 | 公告编号:2026-007 | | --- | --- | --- | | 债券代码:127068 | 债券简称:顺博转债 | | 重庆顺博铝合金股份有限公司 公司同意为上述事项提供连带责任担保,具体以公司与银行签订的 相关担保合同为准。截至本公告披露日,公司对广东顺博的担保余额为 43,780 万元;对安徽顺博的担保余额为 99,036.44 万元;对安徽望博的 担保余额 12,569.76 万元;对顺博销售的担保余额 67,037.03 万元。上 述担保金额在公司股东会审议通过的担保额度范围内,无需另行召开董 事会、股东会审议。本次担保事项不属于关联交易,也不存在反担保的 情形。 三、被担保人基本情况 关于担保事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 一、担保审议情况概述 为满足重庆顺博铝合金股份有限公司(以下简称"公司")下属公 司的业务发展及日常经营资金需求,保障融资事宜顺利进行。公司分别 于 2025 年 12 月 29 日召开第五届董事会第三次会议、2026 年 1 月 ...
顺博合金(002996) - 关于收到重庆证监局行政监管措施决定书的公告
2026-01-29 09:00
| 证券代码:002996 | 证券简称:顺博合金 | 公告编号:2026-008 | | --- | --- | --- | | 债券代码:127068 | 债券简称:顺博转债 | | 重庆顺博铝合金股份有限公司 关于收到重庆证监局行政监管措施决定书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 你公司收到本决定书后应按有关规定及时披露,并自收到本决定书 之日起 30 日内向我局提交书面整改报告。整改报告应包括整改措施、整 改完成时间、整改责任人、内部问责及长效机制的建立等内容,并由你 公司全体董事、高管人员签名确认,加盖公司公章。 如果对本监督管理措施不服的,可以在收到本决定书之日起 60 日内 向中国证券监督管理委员会提出行政复议申请,也可以在收到本决定书 之日起 6 个月内向有管辖权的人民法院提起诉讼。复议与诉讼期间,上 述监督管理措施不停止执行。" (二)中国证券监督管理委员会重庆监管局《关于对王真见、王增 潮、吕路涛采取监管谈话措施的决定》(〔2026〕3 号) 重庆顺博铝合金股份有限公司(以下简称"公司")及相关人员于 近日收到中国证券监 ...
顺博合金:2025年全年净利润同比预增222.96%—315.23%
2 1 Shi Ji Jing Ji Bao Dao· 2026-01-29 08:59
Core Viewpoint - The company, Shunbo Alloy, forecasts a significant increase in net profit for 2025, driven by strong demand in downstream industries and rising prices in the non-ferrous metal market [1] Group 1: Financial Performance - The expected net profit attributable to shareholders for 2025 is projected to be between 21 million and 27 million, representing a year-on-year increase of 222.96% to 315.23% [1] - The net profit after deducting non-recurring gains and losses is anticipated to be between 12.6 million and 18.6 million, reflecting a year-on-year growth of 33.19% to 96.62% [1] Group 2: Factors Driving Performance - The increase in performance is attributed to stronger demand in downstream industries and overall price increases in the non-ferrous metal market, leading to higher sales volume and prices for the company's main products [1] - The company has implemented efficiency reforms that have successfully reduced costs, contributing to an increase in revenue and operating profit year-on-year [1] Group 3: Segment Performance - In the casting aluminum alloy segment, Shunbo Alloy's Anhui subsidiary has a production capacity of 400,000 tons, while the Hubei subsidiary has a capacity of 200,000 tons, both of which have seen steady increases in production and sales, enhancing overall sales scale and profit per ton [1] - In the aluminum plate segment, Chongqing Aobo Aluminum Manufacturing Co., Ltd. has a production capacity of 50,000 tons, with notable increases in sales, particularly for battery casing materials used in the new energy vehicle and energy storage industries, which have positively impacted profit per ton [1]
顺博合金:收到重庆证监局行政监管措施决定书
Xin Lang Cai Jing· 2026-01-29 08:55
顺博合金公告,公司及相关人员收到重庆证监局行政监管措施决定书。公司2024年部分收入存在跨期确 认情形,存货减值测算时确定的可变现净值不合理,导致存货跌价准备计提不充分,未充分考虑个别应 收项目的信用风险情况,导致其他应收款坏账准备计提不充分。上述问题导致公司2024年度财务报告信 息披露不准确。 ...